Dna X (SONM) Change in Accured Expenses (2018 - 2026)

Dna X's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 490.83% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 136.99% YoY) and the FY2025 annual result came in at -$2.0 million, down 124.47% from the prior year.
• Change in Accured Expenses was -$1.3 million for Q1 2026 at Dna X, up from -$1.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $9.8 million in Q3 2024 and bottomed at -$2.8 million in Q4 2024.
• A 5-year average of $338058.8 and a median of $81000.0 in 2022 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 1886.42% in 2023, while the deepest fall reached 778.1% in 2023.
• Dna X's Change in Accured Expenses stood at $81000.0 in 2022, then soared by 1886.42% to $1.6 million in 2023, then plunged by 275.7% to -$2.8 million in 2024, then soared by 31.66% to -$1.9 million in 2025, then soared by 33.33% to -$1.3 million in 2026.
• Business Quant data shows SONM's Change in Accured Expenses at -$1.3 million in Q1 2026, -$1.9 million in Q4 2025, and $1.4 million in Q3 2025.